Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)-Reference-Cited by-同舟云学术

Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Schimanski Carl Christoph¹²^ORCID,Kasper Stefan³,Hegewisch-Becker Susanna⁴,Schröder Jan⁵,Overkamp Friedrich⁶,Kullmann Frank⁷,Bechstein Wolf Otto⁸,Vöhringer Matthias⁹,Öllinger Robert¹⁰,Lordick Florian¹¹,Heinemann Volker¹²,Geißler Michael¹³,Schulz-Abelius Armin¹⁴,Bernhard Helga¹⁵,Schön Michael R.¹⁶,Greil Richard¹⁷,Galle Peter¹,Lang Hauke¹⁸^ORCID,Schmidtmann Irene¹⁹,Moehler Markus¹

Affiliation:

1. Medical Department 1, Johannes Gutenberg University, Mainz, Germany

2. Department of Gastroenterology, Hospital Darmstadt GmbH, Darmstadt, Germany

3. Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany

4. Hematological and Oncological Practice Eppendorf (HOPE), Practice for Oncology, Hamburg, Germany

5. Practice for Hematology and Oncology, Müllheim a.d.R., Germany

6. Oncologianova GmbH Recklinghausen, Recklinghausen, Germany

7. Department of Medicine I, Nordoberpfalz Clinics AG, Weiden i.d.O, Germany

8. Department of General and Visceral Surgery, Frankfurt University Hospital and Clinics, Frankfurt, Germany

9. Department of Hematology and Oncology, Robert Bosch Hospital, Stuttgart, Germany

10. Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany

11. University Cancer Center Leipzig (UCCL), University Hospital Leipzig, Leipzig, Germany

12. Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Grosshadern, Ludwig Maximilian University of Munich, Munich, Germany

13. Department of Internal Medicine, Oncology/Hematology, Gastroenterology, Hospital Esslingen GmbH, Esslingen, Germany

14. Department of Hematology and Oncology, Hospital Altenburger Land GmbH, Altenburg, Germany

15. Department of Hematology/Oncology, Klinikum Darmstadt GmbH, Darmstadt, Germany

16. Clinic of Visceral Surgery, Municipal Hospital Karlsruhe gGmbH, Karlsruhe, Germany

17. Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-CCCIT, Cancer Cluster, Salzburg, Austria

18. Department of General, Visceral and Transplantation Surgery, University Hospital of Mainz, Mainz, Germany

19. Institute for Medical Biostatistics, Epidemiology and Informatics, Johannes Gutenberg-University Mainz, Mainz, Germany

Funder

Merck KGaA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1806680

Reference44 articles.

1. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

2. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Colon cancer (Version 4). (2018). https://www.nccn.org. Accessed August 1st, 2020.

3. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Rectal cancer (Version 3). (2018). https://www.nccn.org. Accessed August 1st, 2020.

4. Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis

5. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies;International Journal of Molecular Sciences;2024-08-30

2. Exploring Cancer Immunotherapy and the Promise of Cancer Vaccine;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

3. Cellular and transcriptional profiles of peripheral blood mononuclear cells pre-vaccination predict immune response to preventative MUC1 vaccine;2024-06-18

4. Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention;2024-05-10

5. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs;Experimental Hematology & Oncology;2024-01-22